Compare EVTL & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVTL | NAUT |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United Kingdom | United States |
| Employees | 454 | N/A |
| Industry | Aerospace | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.7M | 383.5M |
| IPO Year | N/A | 2020 |
| Metric | EVTL | NAUT |
|---|---|---|
| Price | $2.43 | $2.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $12.70 | $4.00 |
| AVG Volume (30 Days) | ★ 2.9M | 321.0K |
| Earning Date | 03-24-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.62 |
| 52 Week High | $7.60 | $4.31 |
| Indicator | EVTL | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 38.11 |
| Support Level | $2.20 | $2.19 |
| Resistance Level | $2.85 | $2.54 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 35.40 | 3.70 |
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.